AVE 0.00% 0.3¢ avecho biotechnology limited

Ann: First Patient dosed in Phase III insomnia trial, page-11

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 315 Posts.
    lightbulb Created with Sketch. 9
    It would be expecting too much for there to be another update on the trial before the AGM. Would be nice, though.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.